PMS9 Biologic Therapy Patterns and Associated Costs in Rheumatoid Arthritis Patients Who Initiated a Tumor Necrosis Factor Antagonist Over Two Years

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.198

Related search